A61K 38/05(20130101), A61K 31/69(20130101), A61K 31/7064(20130101), A61K 31/7076(20130101)
This application relates to combination therapies including triciribine and related compounds and bortezomib and derivatives thereof analogs and compositions with reduced toxicity for the treatment and prevention of tumors, cancer, and other disorders associated with abnormal cell proliferation.
Cheng, Jin Q. and Sebti, Said M., "Compositions including triciribine and bortezomib and derivatives thereof and methods of use thereof" (2015). USF Patents. 71.
University of South Florida